Commentary: Preclinical Efficacy of Immune-Checkpoint Monotherapy Does Not Recapitulate Corresponding Biomarkers-Based Clinical Predictions in Glioblastoma by Garg Et Al. (2017)
OncoImmunology - United States
doi 10.1080/2162402x.2018.1548242
Full Text
Open PDFAbstract
Available in full text
Date
December 13, 2018
Authors
Publisher
Informa UK Limited